复方丹参滴丸对冠心病PCI后血液流变学的影响

Effect of Compound Danshen Dripping Pill on Hemorheology in Patients with Coronary Heart Disease after PCI

目的分析复方丹参滴丸对冠心病PCI后血液流变学的影响,评价用药价值。方法以医院心导管室收治并行PCI治疗的84冠心病患者作为研究对象,均按照常规路径处理,观察组42例患者术前口服复方丹参滴丸,出院后继续服用3个月,对比入院时以及术后24 h血液流变学指标变化以及心血管事件发生情况。结果观察组与对照组差异具有统计学意义(P<0.05)。结论术前应用复方丹参滴丸可改善血流动力学,但无法有效预防术后早期并发症,持续用药可降低远期并发症发生风险。

Objective To study the effect of compound Danshen dripping pills on hemorheology in patients with coronary heart disease after PCI, and to evaluate the value of PCI. Methods 84 patients with coronary heart disease treated with PCI in the hospital were treated as the research object, and 42 patients were treated with the conventional treatment. The patients were treated with oral compound Danshen dripping pills before and after hospital discharge and 3 months after discharge. Results The difference between the observation group and the control group was statistically significant（P〈0.05）. Conclusion Compound Danshen dripping pills can improve the hemodynamics, but can not effectively prevent postoperative complications, and continuous use can reduce the risk of long-term complications.